Jonas L. Isaksen

Vajira Thambawita, Jonas L. Isaksen, Jørgen K. Kanters et al.

Deep learning has achieved expert-level performance in automated electrocardiogram (ECG) diagnosis, yet the "black-box" nature of these models hinders their clinical deployment. Trust in medical AI requires not just high accuracy but also transparency regarding the specific physiological features driving predictions. Existing explainability methods for ECGs typically rely on post-hoc approximations (e.g., Grad-CAM and SHAP), which can be unstable, computationally expensive, and unfaithful to the model's actual decision-making process. In this work, we propose the ECG-IMN, an Interpretable Mesomorphic Neural Network tailored for high-resolution 12-lead ECG classification. Unlike standard classifiers, the ECG-IMN functions as a hypernetwork: a deep convolutional backbone generates the parameters of a strictly linear model specific to each input sample. This architecture enforces intrinsic interpretability, as the decision logic is mathematically transparent and the generated weights (W) serve as exact, high-resolution feature attribution maps. We introduce a transition decoder that effectively maps latent features to sample-wise weights, enabling precise localization of pathological evidence (e.g., ST-elevation, T-wave inversion) in both time and lead dimensions. We evaluate our approach on the PTB-XL dataset for classification tasks, demonstrating that the ECG-IMN achieves competitive predictive performance (AUROC comparable to black-box baselines) while providing faithful, instance-specific explanations. By explicitly decoupling parameter generation from prediction execution, our framework bridges the gap between deep learning capability and clinical trustworthiness, offering a principled path toward "white-box" cardiac diagnostics.

Arjan Mahmuod, Adrian Rod Hammerstad, Muzaffar Yousef et al.

Deep learning models for atrial fibrillation (AF) detection are increasingly trained on heterogeneous electrocardiogram (ECG) datasets with varying sampling frequencies, yet the specific consequences of these discrepancies on model performance, calibration, and robustness remain insufficiently characterized. To address this, we conducted a systematic benchmark using 12-lead, 10-second recordings from the PTB-XL dataset, resampled to target frequencies of 62, 100, 250, and 500 Hz, to evaluate a standard 1-D Convolutional Neural Network (CNN) and a hybrid CNN-Long Short-Term Memory (LSTM) architecture under a rigorous patient-safe cross-validation framework. Our analysis reveals that sampling frequency significantly impacts detection metrics in an architecture-dependent manner; the hybrid CNN-LSTM model demonstrated optimal performance and consistent calibration at intermediate frequencies (100-250 Hz), whereas the 1-D CNN baseline exhibited marked degradation in accuracy and sensitivity at 500 Hz, suggesting increased susceptibility to high-frequency noise. We conclude that ECG sampling frequency is a critical, underappreciated factor in arrhythmia detection, and future foundation models must explicitly control for temporal resolution to ensure clinical reliability and reproducibility.